On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
This is the first update to the original CTS communication distributed on July 6th. As previously co...